Panel

Collaborating Partner

Information on Panel composition and the Conflict of Interest Policy can be found in Methods Table 1; financial relationships between Panel members and commercial firms are listed in the Disclosure Table.

Chairs

Baylor University Medical Center (retired)
The University of Alabama at Birmingham
University of Chicago Medical Center
The Johns Hopkins University School of Medicine
National Institutes of Health

Panel Members

University of Chicago Medical Center
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
Intermountain Medical Center
Veterans Affairs Long Beach Healthcare System
Harvard Medical School
Duke University School of Medicine
Durham VA Medical Center
Toronto Western Hospital Liver Center
Harm Reduction Coalition
University of Michigan Medical School
University of Chicago Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases
National Institutes of Health
University of California San Diego
Bach and Godofsky, MD PA
University of Cincinnati College of Medicine
Harvard Medical School
The Johns Hopkins University School of Medicine
Division of Infectious Diseases
Institute of Human Virology/University of Maryland
College of Medicine, Mayo Clinic
Weill Cornell Medical College
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
University of Miami School of Medicine
University of California San Diego

*Individual employees of the National Institutes of Health (NIH) have participated in the planning and development of the Guidance, although the NIH is not an official sponsor.

**The views expressed by the participants do not necessarily represent the opinions of the Centers for Disease Control and Prevention, the National Institutes of Health, or the Department of Health and Human Services.

+ Non-voting Panel members

Contributors and Technical Advisors

Saleem Kamili, PhD**
Division of Viral Hepatitis
Deputy Chief, Laboratory Branch, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
For contributing to development of the Testing and Linkage to Care Table 1: FDA-approved, Commercially Available Anti-HCV Screening Assays
Judith Welsh, BS, MLS* **
Clinical Informationist
NIH Library
National Institutes of Health
For performing comprehensive literature searches to identify the evidence used to prepare the Guidance
Rachel J. Wilson**
Division of Viral Hepatitis
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
For comprehensive copy editing and styling of the final Guidance

IAS-USA Production Staff and Consultants

Cindy Downing
IAS-USA
Project coordination and administrative support
Michelle Valderama
IAS-USA
Web maintenance and management
Jennezel Peneda
IAS-USA
Web production and management